Henry Schein and Mattel Fell on February 13
Henry Schein (HSIC), which is a distributor of healthcare products and services, was among the S&P 500’s top losers on February 13. Following a weak performance for two weeks, Henry Schein started this week on a mixed note and fell to three-month low price levels on Tuesday.
Interested in HSIC? Don't miss the next report.
Receive e-mail alerts for new research on HSIC
The selling pressure in Henry Schein increased on Tuesday amid reports of a lawsuit. According to reports, the Federal Trade Commission filed antitrust lawsuits against Benco Dental Supply, Henry Schein, and Patterson Companies (PDCO). As a result, there was a sell-off in Henry Schein, which fell as much as 13% in the early hours on Tuesday. According to reports, the trial to review these antitrust lawsuits will be held in October.
On February 13, Henry Schein declined 6.6% and closed the day at $67.39. Henry Schein is part of the S&P 500 healthcare sector, which gained 0.05% on Tuesday.
Mattel (MAT), which is an American multinational toy manufacturing company, was among the S&P 500’s top losers on Tuesday. After regaining strength last week, Mattel started this week on a mixed note and declined on Tuesday.
Mattel lost strength on Tuesday following the announcement of its new game “Dos.” In an attempt to restore Mattel’s business strength by updating classic brands, the company plans to launch its new card game “Dos” in Target stores and other stores in August. On February 13, Mattel declined 5.8% and closed the day at $16.36. Mattel is part of the S&P 500 consumer discretionary sector, which gained 0.51% on Tuesday.